Postbus 90203
Amsterdam, 1006 BE
Netherlands
Radiotherapy, Anti-PD-1, Pembrolizumab, Pooled analysis, Metastatic Non-Small Cell Lung Cancer
Mesothelioma; gemcitabine; maintenance; randomised; NVALT; phase II